Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience. Berlanga P, Pasqualini C, Potschger U, Sanguesa C, et al. Eur J Cancer 2021;144:1-8.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Berlanga P, Pasqualini C, Potschger U, Sanguesa C, et al. Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience. Eur J Cancer 2021;144:1-8.
PMID: 33316634